Eli Lilly: In type 2 diabetes trials, Orforglipron outperforms Semaglutide in both blood sugar control and weight loss.
Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Glonghui, February 26th｜Eli Lilly stated that in type 2 diabetes trials, its oral GLP-1 drug Orforglipron outperformed Novo Nordisk's oral semaglutide in both blood sugar control and weight loss. Applications for Orforglipron have been submitted to regulatory agencies in more than 40 countries, and the company expects to initiate the obesity indication approval process in the United States in the second quarter of 2026.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now！
You may also like
Silver Price Forecast: XAG/USD awaits move beyond $50.00 to extend recovery from YTD low
FXStreet•2026/11/02 03:33
UKMTO reports two projectiles strike tanker off Saudi Arabia's coast
FXStreet•2026/11/02 02:33
Aging and High Debt Pressure: Europe's Pension Dilemma Spills Over to Sovereign Debt Markets
Europe's aging population and rising government debt are placing increasing pressure on public pension systems, sparking market concerns over fiscal stability.
智通财经•2026/11/02 02:26
Crypto prices
More
Bitcoin
BTC
$78,528.91
+1.13%
Ethereum
ETH
$2,305.42
+1.75%
Tether USDt
USDT
$0.9987
-0.00%
BNB
BNB
$713.78
+1.59%
XRP
XRP
$1.26
+0.74%
USDC
USDC
$0.9997
-0.01%
Solana
SOL
$95.47
+0.02%
TRON
TRX
$0.3135
+1.37%
Hyperliquid
HYPE
$87.92
-0.19%
Zcash
ZEC
$1,264.75
+1.79%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now